Search results for "Executive dysfunction"

showing 6 items of 16 documents

Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort

2021

Bipolar disorder is associated with an increased risk of dementia with aging. Little is known regarding this association, limiting appropriate diagnosis and management. We aimed to describe the characteristics of bipolar patients with late cognitive impairment for whom the hypothesis of an underlying neurodegenerative disease had been raised. We performed a retrospective multicenter study, recruiting bipolar patients over 50 years old from five French tertiary memory centers who had undergone cerebrospinal fluid (CSF) biomarker assessment for Alzheimer’s disease (AD). Clinical, neuropsychological, and paraclinical characteristics were analyzed and 78 patients were included. The mean age at …

cognitionmedicine.medical_specialty[SDV]Life Sciences [q-bio]Medicine (miscellaneous)ParkinsonismArticleInternal medicinemedicineDementiaBipolar disorderbipolar disorderbusiness.industryParkinsonismneurodegenerescenceNeuropsychologyRbiomarkersCognitionmedicine.disease[SDV] Life Sciences [q-bio]Biomarker (medicine)MedicinebusinessNeurocognitiveAlzheimer’s diseaseExecutive dysfunctiondementia
researchProduct

PATH56 MRI correlates of vascular cognitive impairment: contribution of microbleeds, white matter changes and infarcts in a large hospital-based cros…

2010

Background The mechanisms underlying vascular cognitive impairment remain poorly understood. Brain microbleeds may contribute, particularly to executive dysfunction. We investigated the cognitive effects of microbleeds and other neuroimaging markers for cerebrovascular disease in a large, hospital-based study. Methods Consecutive, unselected patients referred to the stroke unit or clinic underwent clinical assessment, detailed neuropsychological testing and vascular MRI. Microbleeds, white matter changes (WMC) and brain infarcts were identified and their effects on cognition assessed. Results 242 patients were included (N=60 with, N=182 without microbleeds). Executive impairment was more pr…

medicine.medical_specialtyCross-sectional studyCognitionHospital basedmedicine.diseaseWhite matter changescerebrovascular diseasePsychiatry and Mental healthNeuroimagingInternal medicinemedicineCardiologySurgeryNeurology (clinical)PsychologyPsychiatryCognitive impairmentStrokeExecutive dysfunctionJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Association Between Fatigue and Cognitive Impairment at 6 Months in Patients With Ischemic Stroke Treated With Acute Revascularization Therapy.

2019

Background: Fatigue is a frequent symptom after stroke. We aimed to determine the association between fatigue and cognitive performance in patients with ischemic stroke who received acute revascularization therapy (IV thrombolysis and/or mechanical thrombectomy).Methods: Seventy patients were prospectively included in the stroke unit of the University Hospital of Dijon, France. A follow-up was performed at 6 months with clinical examination, fatigue assessment by the Fatigue Severity Scale (FSS), and a comprehensive neuropsychological evaluation. Patients with fatigue (FSS score >4) were compared with patients without fatigue. Neuropsychological factors associated with fatigue at 6 month…

medicine.medical_specialtyPhysical examinationlcsh:RC346-42903 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineischemic strokeMedicineMemory impairment030212 general & internal medicineCognitive rehabilitation therapyEffects of sleep deprivation on cognitive performanceStrokelcsh:Neurology. Diseases of the nervous systemDepression (differential diagnoses)Original Researchcognitive impairmentmedicine.diagnostic_testbusiness.industrymedicine.diseasestrokeNeurologydepressionoutcomefatigueNeurology (clinical)business030217 neurology & neurosurgeryExecutive dysfunctionFrontiers in neurology
researchProduct

Cognitive effects of labeled addictolytic medications

2017

Abstract Introduction Alcohol, tobacco, and illegal drug usage is pervasive throughout the world, and abuse of these substances is a major contributor to the global disease burden. Many pharmacotherapies have been developed over the last 50 years to target addictive disorders. While the efficacy of these pharmacotherapies is largely recognized, their cognitive impact is less known. However, all substance abuse disorders are known to promote cognitive disorders like executive dysfunction and memory impairment. These impairments are critical for the maintenance of addictive behaviors and impede cognitive behavioral therapies that are regularly administered in association with pharmacotherapie…

medicine.medical_specialtySubstance-Related Disordersmedia_common.quotation_subjectAlcohol abuse03 medical and health scienceschemistry.chemical_compoundCognition0302 clinical medicinemedicineAnimalsHumansVareniclinePsychiatryBiological PsychiatryNalmefenemedia_commonPharmacologyAddictionCognitionmedicine.disease030227 psychiatrySubstance abusechemistryPsychology030217 neurology & neurosurgeryCentral Nervous System AgentsClinical psychologymedicine.drugExecutive dysfunctionBuprenorphineProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Editorial: Unawareness of Illness in Neurological Disorders: A Focussed Neurocognitive Approach Shedding Light on Neuropsychological Deficits and Neu…

2020

neuroimagingtheoretical modelsassessmentassessment; electrophysiological techniques; executive dysfunction; illness unawareness; neurodegenerative and vascular brain injuries; neuroimaging; theoretical modelslcsh:BF1-990neurodegenerative and vascular brain injuriesMEDLINETheoretical modelsNeuropsychologyexecutive dysfunctionillness unawarenesselectrophysiological techniqueslcsh:PsychologyEditorialNeuroimagingPsychologyPsychologyAssociation (psychology)NeurocognitiveGeneral PsychologyExecutive dysfunctionClinical psychologyFrontiers in psychology
researchProduct

Neuropsychological Alterations in Children Affected by Obstructive Sleep Apnea Syndrome

2020

Sleep-related breathing disorders are a group of clinical conditions ranging from habitual snoring to obstructive sleep apnea syndrome (OSAS) during the lifespan. In children, other risk factors are represented by adenotonsillar hypertrophy, rhinitis, nasal structure alteration, cleft palate, velopharyngeal flap surgery, pharyngeal masses, craniofacial malformations, genetic syndrome (i.e. Down syndrome, Crouzon syndrome, and Apert syndrome), genetic hypoplasia mandibular (i.e. Pierre Robin syndrome, Treacher Collins syndrome, Shy-Drager syndrome, and Cornelia De Lange syndrome), craniofacial traumas, chronic or seasonal rhinitis, asthma, neuromuscular syndromes, brainstem pathologies (i.e.…

pediatric OSASPediatricsmedicine.medical_specialtybusiness.industryInformationSystems_INFORMATIONSTORAGEANDRETRIEVALexecutive dysfunctionNeuropsychologymedicine.diseasesleep-related breathing disorders pediatric OSAS executive dysfunctionObstructive sleep apneamedicinesleep-related breathing disorderbusinessGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Executive dysfunction
researchProduct